top of page

LEAXOLAR CAPSULES 110 mg

Product details

Registration number: SIN17425P

Classification: Prescription Only

Active ingredients: Dabigatran etexilate mesilate eqv dabigatran etexilate

Strength: 110 mg

Dosage form: CAPSULE

Route: ORAL

Registrant: LOTUS INTERNATIONAL PTE. LTD.

ATC code: B01AE07

HSA approval date: 31 December 2025

Manufacturer(s): OMAN PHARMACEUTICAL PRODUCTS COMPANY LLC

Manufacturing country/countries: OMAN

What are the HSA registration number and classification for LEAXOLAR CAPSULES 110 mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17425P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for LEAXOLAR CAPSULES 110 mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Dabigatran etexilate mesilate eqv dabigatran etexilate

Strength: 110 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for LEAXOLAR CAPSULES 110 mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: CAPSULE

Route: ORAL

Source for this answer

Who is the recorded registrant for LEAXOLAR CAPSULES 110 mg?

According to the HSA dataset updated 7 August 2026:

Registrant: LOTUS INTERNATIONAL PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for LEAXOLAR CAPSULES 110 mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): OMAN PHARMACEUTICAL PRODUCTS COMPANY LLC

Manufacturing country/countries: OMAN

Source for this answer

Where can I look up LEAXOLAR CAPSULES 110 mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17425P or the exact product name LEAXOLAR CAPSULES 110 mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this LEAXOLAR CAPSULES 110 mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this LEAXOLAR CAPSULES 110 mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17425P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page